52 related articles for article (PubMed ID: 24605912)
21. The multisubstrate adapter Gab1 regulates hepatocyte growth factor (scatter factor)-c-Met signaling for cell survival and DNA repair.
Fan S; Ma YX; Gao M; Yuan RQ; Meng Q; Goldberg ID; Rosen EM
Mol Cell Biol; 2001 Aug; 21(15):4968-84. PubMed ID: 11438654
[TBL] [Abstract][Full Text] [Related]
22. Human acute myelogenous and lymphoid leukemias: pattern of expression of cellular oncogenes.
Sposi NM; Mavilio F; Petrini M; Bottero L; Zappavigna V; Mastroberardino G; De Rossi G; Amadori S; Mandelli F; Peschle C
Haematologica; 1987; 72(6 Suppl):23-6. PubMed ID: 3127292
[No Abstract] [Full Text] [Related]
23. Polo-like kinases in AML.
Berg T; Bug G; Ottmann OG; Strebhardt K
Expert Opin Investig Drugs; 2012 Aug; 21(8):1069-74. PubMed ID: 22667760
[TBL] [Abstract][Full Text] [Related]
24. Identification of major ERK-related phosphorylation sites in Gab1.
Lehr S; Kotzka J; Avci H; Sickmann A; Meyer HE; Herkner A; Muller-Wieland D
Biochemistry; 2004 Sep; 43(38):12133-40. PubMed ID: 15379552
[TBL] [Abstract][Full Text] [Related]
25. High Expression of Human Homologue of Murine Double Minute 4 and the Short Splicing Variant, HDM4-S, in Bone Marrow in Patients With Acute Myeloid Leukemia or Myelodysplastic Syndrome.
Han X; Medeiros LJ; Zhang YH; You MJ; Andreeff M; Konopleva M; Bueso-Ramos CE
Clin Lymphoma Myeloma Leuk; 2016 Aug; 16 Suppl():S30-8. PubMed ID: 27155969
[TBL] [Abstract][Full Text] [Related]
26. The expression of LMO2 protein in acute B-cell and myeloid leukemia.
Cobanoglu U; Sonmez M; Ozbas HM; Erkut N; Can G
Hematology; 2010 Jun; 15(3):132-4. PubMed ID: 20557670
[TBL] [Abstract][Full Text] [Related]
27. Identification of a fusion gene composed of a Hippo pathway gene MST2 and a common translocation partner ETV6 in a recurrent translocation t(8;12)(q22;p13) in acute myeloid leukemia.
Ogawa S; Yokoyama Y; Suzukawa K; Nanmoku T; Kurita N; Seki M; Maie K; Suyama T; Takaiwa N; Sakata-Yanagimoto M; Obara N; Hasegawa Y; Chiba S
Ann Hematol; 2015 Aug; 94(8):1431-3. PubMed ID: 25933678
[No Abstract] [Full Text] [Related]
28. Superenhancing AML with Trib1.
Keeshan K
Blood; 2021 Jan; 137(1):8-9. PubMed ID: 33410899
[No Abstract] [Full Text] [Related]
29. LATS1 Promotes B-ALL Tumorigenesis by Regulating YAP1 Phosphorylation and Subcellular Localization.
Zhang F; Issah MA; Fu HY; Zhou HR; Liu TB; Shen JZ
Curr Med Sci; 2024 Feb; 44(1):81-92. PubMed ID: 38277019
[TBL] [Abstract][Full Text] [Related]
30. Hippo pathway-related genes expression is deregulated in myeloproliferative neoplasms.
Cacemiro MDC; Cominal JG; Pereira LM; Berzoti-Coelho MG; Berbel GM; Baroni L; Malta T; Tognon R; Nunes NS; Souto EX; de Figueiredo-Pontes LL; Yatsuda AP; de Castro FA
Med Oncol; 2022 May; 39(5):97. PubMed ID: 35599283
[TBL] [Abstract][Full Text] [Related]
31. ANKHD1 promotes proliferation and invasion of non‑small‑cell lung cancer cells via regulating YAP oncoprotein expression and inactivating the Hippo pathway.
Liu XF; Han Q; Rong XZ; Yang M; Han YC; Yu JH; Lin XY
Int J Oncol; 2020 May; 56(5):1175-1185. PubMed ID: 32319569
[TBL] [Abstract][Full Text] [Related]
32. Knockdown of the Hippo transducer YAP reduces proliferation and promotes apoptosis in the Jurkat leukemia cell.
Wu R; Yang H; Wan J; Deng X; Chen L; Hao S; Ma L
Mol Med Rep; 2018 Dec; 18(6):5379-5388. PubMed ID: 30320399
[TBL] [Abstract][Full Text] [Related]
33. Expression of Hippo signaling pathway and Aurora kinase genes in chronic myeloid leukemia.
Marsola APZC; Simões BP; Palma LC; Berzoti-Coelho MG; Burin SM; de Castro FA
Med Oncol; 2018 Jan; 35(3):26. PubMed ID: 29387948
[TBL] [Abstract][Full Text] [Related]
34. YAP and the Hippo pathway in pediatric cancer.
Ahmed AA; Mohamed AD; Gener M; Li W; Taboada E
Mol Cell Oncol; 2017; 4(3):e1295127. PubMed ID: 28616573
[TBL] [Abstract][Full Text] [Related]
35. Valproic acid may exerts its cytotoxic effect through rassf1a expression induction in acute myeloid leukemia.
Davood ZA; Shamsi S; Ghaedi H; Sahand RI; Mojtaba G; Mahdi T; Reza M; Ebrahimi MJ; Miri-Moosavi RS; Boosaliki S; Davood OM
Tumour Biol; 2016 Aug; 37(8):11001-6. PubMed ID: 26894600
[TBL] [Abstract][Full Text] [Related]
36. YAP1 expression in myelodysplastic syndromes and acute leukemias.
Machado-Neto JA; de Melo Campos P; Olalla Saad ST; Traina F
Leuk Lymphoma; 2014 Oct; 55(10):2413-5. PubMed ID: 24605912
[No Abstract] [Full Text] [Related]
37. MST1/2 and YAP1 gene expression in acute myeloid leukemia.
Safari S; Movafagh A; Zare-Adollahi D; Ghadiani M; Riazi-Isfahani S; Safavi-Naini N; Omrani MD
Leuk Lymphoma; 2014 Sep; 55(9):2189-91. PubMed ID: 24303784
[No Abstract] [Full Text] [Related]
38. Elevated PIM2 gene expression is associated with poor survival of patients with acute myeloid leukemia.
Kapelko-Slowik K; Owczarek TB; Grzymajlo K; Urbaniak-Kujda D; Jazwiec B; Slowik M; Kuliczkowski K; Ugorski M
Leuk Lymphoma; 2016 Sep; 57(9):2140-9. PubMed ID: 26764044
[TBL] [Abstract][Full Text] [Related]
39. Targeted therapies: Hippo effector YAP1 inhibition—towards a new therapeutic option to overcome drug resistance.
Errico A
Nat Rev Clin Oncol; 2015 Apr; 12(4):190. PubMed ID: 25707626
[No Abstract] [Full Text] [Related]
40. The DeMSTification of mammalian Ste20 kinases.
Radu M; Chernoff J
Curr Biol; 2009 May; 19(10):R421-5. PubMed ID: 19467213
[TBL] [Abstract][Full Text] [Related]
[Previous] [Next] [New Search]
